Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.
about
Cholinergic deficiency hypothesis in delirium: a synthesis of current evidenceA subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviorsBiomarkers of postoperative delirium and cognitive dysfunctionDistribution and effects of the muscarinic receptor subtypes in the primary visual cortexTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesDeep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic DataThe Role of Hippocampal NMDA Receptors in Long-Term Emotional Responses following Muscarinic Receptor ActivationAssociation between the CHRM2 gene and intelligence in a sample of 304 Dutch familiesCholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's diseaseScopolamine administration modulates muscarinic, nicotinic and NMDA receptor systemsThe regulation of M1 muscarinic acetylcholine receptor desensitization by synaptic activity in cultured hippocampal neuronsThe antipsychotic potential of muscarinic allosteric modulationAllosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's diseaseKnockdown of phospholipase C-β1 in the medial prefrontal cortex of male mice impairs working memory among multiple schizophrenia endophenotypesM-type potassium channels modulate Schaffer collateral-CA1 glutamatergic synaptic transmission.Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system.A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairmentMechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline bindingHypoglycemia induced changes in cholinergic receptor expression in the cerebellum of diabetic rats.Genetic dissection of theta rhythm heterogeneity in mice.N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brain.Role of the central cholinergic system in the therapeutics of schizophrenia.Preliminary evidence for associations of CHRM2 with substance use and disinhibition in adolescence.Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.Acetylcholine induces mesenchymal stem cell migration via Ca2+ /PKC/ERK1/2 signal pathway.Ethanol impairs muscarinic receptor-induced neuritogenesis in rat hippocampal slices: Role of astrocytes and extracellular matrix proteins.Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderRegulation of synaptic MAPK/ERK phosphorylation in the rat striatum and medial prefrontal cortex by dopamine and muscarinic acetylcholine receptors.CHRM2, parental monitoring, and adolescent externalizing behavior: evidence for gene-environment interaction.Neuronal localization of m1 muscarinic receptor immunoreactivity in the rat basolateral amygdalaA rapid and efficient analytical method for the quantification of a novel anticholinergic compound, R-phencynonate, by stable isotope-dilution LC-MS/MS and its application to bioavailability and dose proportionality studies.Cholinergic coordination of presynaptic and postsynaptic activity induces timing-dependent hippocampal synaptic plasticity.Exploring the functional role of the CHRM2 gene in human cognition: results from a dense genotyping and brain expression study.Cell-type-specific modulation of neocortical activity by basal forebrain input.Cholinergic modulation of response gain in the rat primary visual cortex.Serum biomarkers for delirium.Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons.Perisomatic GABA release and thalamocortical integration onto neocortical excitatory cells are regulated by neuromodulators.Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.
P2860
Q24594565-1D347F25-BC62-4D2B-AC8F-23CF3D1940AEQ24645678-4FBF1023-A57B-44D0-AD9B-24D707D2A0E4Q26830796-74AAF362-ECC4-44A8-9782-6E0D868D6E09Q26851426-4F5D6D88-227D-4A98-BD60-593E4AEF3E3BQ27023257-3A0AC789-9585-4C08-8F58-365E6F0DC79CQ27301054-C4E8FE7B-A2D9-4CAB-B4F8-5772B20BB3E7Q27329061-BFF7F1BB-4D87-418F-A359-77638053B1D7Q28271932-E0796622-D884-41A4-803D-76F886622DC2Q28287090-7B54E460-3075-406D-A2FB-475479104CF4Q28481245-71D75CE7-2182-4D73-9BCE-0F39FBD46693Q28577190-3EB78170-9520-48A6-962E-7574FEEF14DAQ28603221-A1FCD01E-3210-4B66-90C9-74E00C85F799Q28660933-C45040D3-2D82-4CF3-8ADD-B6C461BCE71BQ30415009-8A354E40-13EB-4736-8964-0A1B605C0B90Q30455624-FDEE1C43-6F2A-4F40-820C-7C50B27C4C14Q30474039-D711152E-5B56-4E48-BFD5-AD380B2237FDQ30475205-FEC8C4FC-2317-4C92-BE02-017E25881FFDQ33714489-5B1EE1DF-FF81-4CC3-9D25-4F33AB4F0906Q33753506-C25950AB-0AA9-4CD9-A66C-A381A9A1CADFQ34193893-499F253F-2D29-4A9D-BDE3-D7604572524FQ34419652-EE886FEC-1533-40B0-BBD4-355B56DDD0DEQ34452590-B36BF021-12AD-419E-9D24-9A1C9986419AQ34608625-264815C0-03CB-4F76-847A-C1C04BEADDADQ34626957-8753F83B-8165-474D-BD20-21C2D32DF739Q34653803-AA80181C-682C-4A74-9FDE-E692B25B9E67Q34683797-73F262A7-8E58-4D8D-83F6-47A8549EEFFDQ35489314-56D76E58-50E2-4E90-80B9-0D58DF5FEFECQ35546189-E74911D5-5534-4B8A-9E3C-31AAE035C288Q35985571-A663CE5A-186F-4FDD-B485-295589516F69Q36082664-F4138E28-060F-4865-8F2E-6A4964A34268Q36100377-E1249A30-CF8A-4C50-AED0-E86468053A74Q36176850-897784DA-4B9C-4CF9-BF05-0311F0023BC3Q36326453-6CFF6D32-CA95-4182-AEBF-A2E64382D42DQ36380183-2797D6A1-55F3-4776-B61C-34FDF6B3281BQ36520597-5558C637-F208-408A-A972-DE8ADD75E396Q36576152-0E03C391-40BB-43F7-9662-379B00D8D434Q36712025-F3D643FA-2002-4258-84D4-2330851E0FE6Q36718078-524DDACE-87A7-4225-ADFE-10B801A7FCEFQ36948049-732A081D-9668-427C-BDA2-8A83E27A39F0Q37118153-46269649-F657-4876-8294-4180CA896CFA
P2860
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.
@ast
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.
@en
type
label
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.
@ast
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.
@en
prefLabel
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.
@ast
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.
@en
P1476
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.
@en
P2093
Allan I Levey
Laura A Volpicelli
P356
10.1016/S0079-6123(03)45003-6
P577
2004-01-01T00:00:00Z